Wiegant V M, Verhoef C J, Burbach J P, de Wied D
Rudolf Magnus Institute for Pharmacology, State University of Utrecht, The Netherlands.
Life Sci. 1988;42(18):1733-42. doi: 10.1016/0024-3205(88)90039-2.
The concentrations of alpha-, beta- and gamma-endorphin were determined by radioimmunoassay in HPLC fractionated extracts of post mortem hypothalamic tissue obtained from schizophrenic patients and controls. The hypothalamic concentration of alpha- and gamma-endorphin was significantly higher in patients than in controls (+72.9% and +50.5% respectively). No difference was found in the concentration of beta-endorphin, the putative precursor of alpha- and gamma-endorphins. These results suggest a deviant metabolism of beta-endorphin in the brain of schizophrenic patients. Whether this phenomenon is related to the psychopathology, or is a consequence of ante mortem farmacotherapy, remains to be established.
采用放射免疫分析法,对取自精神分裂症患者和对照者的死后下丘脑组织经高效液相色谱法分离的提取物中的α-、β-和γ-内啡肽浓度进行了测定。患者下丘脑α-和γ-内啡肽浓度显著高于对照者(分别高出72.9%和50.5%)。在α-和γ-内啡肽的假定前体β-内啡肽浓度方面未发现差异。这些结果提示,精神分裂症患者大脑中β-内啡肽的代谢存在异常。这种现象是否与精神病理学有关,或是生前药物治疗的结果,仍有待确定。